XOMA to acquire Mural Oncology for up to $2.24 per share in cash Aug 20, 2025 08:30AM
Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share Aug 20, 2025 08:30AM
Mural Oncology (MURA) PT Lowered to $4 at Raymond James Apr 15, 2025 12:33PM